Recombinant ones are monoclonal, and here are the key steps involved in their production. Recombinant antibody production involves the use of recombinant DNA technology to produce an antibody.

Recombinant zoster vaccine reduces all-cause mortality in patients with immune-mediated inflammatory diseases receiving Janus ...

By the latter half of this year, the company aims to submit a biologics license application to Korean authorities.

Orion enters agreement with Shilpa Medicare to commercialise recombinant human albumin in European market: Espoo, Finland Monday, May 26, 2025, 11:00 Hrs [IST] Orion Corporation, ...

Hyderabad: Shilpa Medicare Limited, a pharmaceutical and biotechnology company, has announced that its 100 percent subsidiary ...

Shilpa Biocare Private Limited has entered into a strategic partnership with Orion Corporation out-licensing its flagship ...

Huonslab announced the successful completion of patient enrollment in its pivotal phase 1 clinical trial of Hydizyme.

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market ...